nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1A2—Imiquimod—skin cancer	0.0942	0.175	CbGbCtD
Melatonin—CYP1B1—Docetaxel—skin cancer	0.0904	0.168	CbGbCtD
Melatonin—CYP1A1—Dacarbazine—skin cancer	0.0886	0.165	CbGbCtD
Melatonin—CYP2C19—Vismodegib—skin cancer	0.0708	0.132	CbGbCtD
Melatonin—CYP2C9—Vismodegib—skin cancer	0.0588	0.109	CbGbCtD
Melatonin—CYP1A2—Vemurafenib—skin cancer	0.0516	0.0959	CbGbCtD
Melatonin—CYP1A2—Dacarbazine—skin cancer	0.0396	0.0735	CbGbCtD
Melatonin—CYP1A2—Fluorouracil—skin cancer	0.0232	0.0431	CbGbCtD
Melatonin—CYP2C9—Fluorouracil—skin cancer	0.0209	0.0388	CbGbCtD
Melatonin—MT3—nerve—skin cancer	0.00849	0.0557	CbGeAlD
Melatonin—CALR—skin epidermis—skin cancer	0.00786	0.0516	CbGeAlD
Melatonin—IDO1—connective tissue—skin cancer	0.0046	0.0302	CbGeAlD
Melatonin—EPX—lymphoid tissue—skin cancer	0.00444	0.0291	CbGeAlD
Melatonin—EPX—female reproductive system—skin cancer	0.00428	0.0281	CbGeAlD
Melatonin—CALR—nipple—skin cancer	0.0038	0.025	CbGeAlD
Melatonin—CALR—neck—skin cancer	0.00376	0.0247	CbGeAlD
Melatonin—ASMT—female reproductive system—skin cancer	0.00355	0.0233	CbGeAlD
Melatonin—IDO1—lymphoid tissue—skin cancer	0.00336	0.0221	CbGeAlD
Melatonin—CALM2—ear—skin cancer	0.00326	0.0214	CbGeAlD
Melatonin—CALM1—ear—skin cancer	0.00324	0.0213	CbGeAlD
Melatonin—IDO1—female reproductive system—skin cancer	0.00324	0.0213	CbGeAlD
Melatonin—MTNR1B—head—skin cancer	0.00304	0.02	CbGeAlD
Melatonin—ASMT—head—skin cancer	0.00296	0.0194	CbGeAlD
Melatonin—CALR—connective tissue—skin cancer	0.0027	0.0177	CbGeAlD
Melatonin—CALR—epithelium—skin cancer	0.00256	0.0168	CbGeAlD
Melatonin—MPO—endothelium—skin cancer	0.00247	0.0162	CbGeAlD
Melatonin—CALR—skin of body—skin cancer	0.00243	0.016	CbGeAlD
Melatonin—MTNR1A—head—skin cancer	0.0024	0.0158	CbGeAlD
Melatonin—MPO—blood vessel—skin cancer	0.00228	0.015	CbGeAlD
Melatonin—CALR—mammalian vulva—skin cancer	0.00222	0.0146	CbGeAlD
Melatonin—NQO2—nipple—skin cancer	0.00214	0.0141	CbGeAlD
Melatonin—CALM2—nerve—skin cancer	0.00205	0.0135	CbGeAlD
Melatonin—CALM1—nerve—skin cancer	0.00204	0.0134	CbGeAlD
Melatonin—MT3—head—skin cancer	0.00201	0.0132	CbGeAlD
Melatonin—CALR—lymphoid tissue—skin cancer	0.00197	0.0129	CbGeAlD
Melatonin—CALR—female reproductive system—skin cancer	0.0019	0.0125	CbGeAlD
Melatonin—IDO1—lymph node—skin cancer	0.0019	0.0125	CbGeAlD
Melatonin—CYP1B1—hair follicle—skin cancer	0.00186	0.0122	CbGeAlD
Melatonin—CYP1A1—skin epidermis—skin cancer	0.00184	0.0121	CbGeAlD
Melatonin—CALM2—endothelium—skin cancer	0.00175	0.0115	CbGeAlD
Melatonin—CALM1—endothelium—skin cancer	0.00174	0.0114	CbGeAlD
Melatonin—CALM2—hair follicle—skin cancer	0.00172	0.0113	CbGeAlD
Melatonin—ESR1—blood vessel—skin cancer	0.00162	0.0106	CbGeAlD
Melatonin—CALM2—blood vessel—skin cancer	0.00161	0.0106	CbGeAlD
Melatonin—CALM1—blood vessel—skin cancer	0.0016	0.0105	CbGeAlD
Melatonin—CALR—head—skin cancer	0.00159	0.0104	CbGeAlD
Melatonin—CALM3—nipple—skin cancer	0.00148	0.00974	CbGeAlD
Melatonin—MT3—lymph node—skin cancer	0.00141	0.00926	CbGeAlD
Melatonin—NQO2—mammalian vulva—skin cancer	0.00125	0.00822	CbGeAlD
Melatonin—MPO—connective tissue—skin cancer	0.00117	0.00768	CbGeAlD
Melatonin—CALM2—nipple—skin cancer	0.00116	0.00765	CbGeAlD
Melatonin—ESR1—neck—skin cancer	0.00116	0.00761	CbGeAlD
Melatonin—CALM1—nipple—skin cancer	0.00116	0.00761	CbGeAlD
Melatonin—CALM2—neck—skin cancer	0.00115	0.00757	CbGeAlD
Melatonin—CALM1—neck—skin cancer	0.00115	0.00753	CbGeAlD
Melatonin—CALR—lymph node—skin cancer	0.00111	0.0073	CbGeAlD
Melatonin—MPO—epithelium—skin cancer	0.00111	0.00729	CbGeAlD
Melatonin—NQO2—female reproductive system—skin cancer	0.00107	0.00704	CbGeAlD
Melatonin—MPO—skin of body—skin cancer	0.00106	0.00694	CbGeAlD
Melatonin—CYP19A1—connective tissue—skin cancer	0.000956	0.00628	CbGeAlD
Melatonin—CYP1A2—nipple—skin cancer	0.000903	0.00593	CbGeAlD
Melatonin—NQO2—head—skin cancer	0.000896	0.00588	CbGeAlD
Melatonin—CYP1B1—connective tissue—skin cancer	0.000894	0.00587	CbGeAlD
Melatonin—CYP1A1—nipple—skin cancer	0.000891	0.00585	CbGeAlD
Melatonin—CALM3—mammalian vulva—skin cancer	0.000866	0.00569	CbGeAlD
Melatonin—MPO—lymphoid tissue—skin cancer	0.000856	0.00562	CbGeAlD
Melatonin—Lethargy—Dactinomycin—skin cancer	0.000842	0.00412	CcSEcCtD
Melatonin—Asthenia—Vismodegib—skin cancer	0.000833	0.00408	CcSEcCtD
Melatonin—ESR1—connective tissue—skin cancer	0.000831	0.00546	CbGeAlD
Melatonin—CALM2—connective tissue—skin cancer	0.000826	0.00542	CbGeAlD
Melatonin—CALM1—connective tissue—skin cancer	0.000822	0.0054	CbGeAlD
Melatonin—Pruritus—Vismodegib—skin cancer	0.000821	0.00402	CcSEcCtD
Melatonin—CYP1B1—skin of body—skin cancer	0.000807	0.0053	CbGeAlD
Melatonin—Eye disorder—Imiquimod—skin cancer	0.000805	0.00394	CcSEcCtD
Melatonin—Hot flush—Temozolomide—skin cancer	0.000797	0.0039	CcSEcCtD
Melatonin—Menopausal symptoms—Temozolomide—skin cancer	0.000791	0.00387	CcSEcCtD
Melatonin—ESR1—epithelium—skin cancer	0.000789	0.00518	CbGeAlD
Melatonin—CALM2—epithelium—skin cancer	0.000784	0.00515	CbGeAlD
Melatonin—Thirst—Temozolomide—skin cancer	0.000784	0.00384	CcSEcCtD
Melatonin—Angiopathy—Imiquimod—skin cancer	0.000781	0.00382	CcSEcCtD
Melatonin—Nabumetone—PTGS2—skin cancer	0.000781	1	CrCbGaD
Melatonin—CALM1—epithelium—skin cancer	0.000781	0.00512	CbGeAlD
Melatonin—Immune system disorder—Imiquimod—skin cancer	0.000778	0.00381	CcSEcCtD
Melatonin—Disorientation—Fluorouracil—skin cancer	0.000768	0.00376	CcSEcCtD
Melatonin—Liver function test abnormal—Dactinomycin—skin cancer	0.000761	0.00373	CcSEcCtD
Melatonin—Mental disorder—Imiquimod—skin cancer	0.000754	0.00369	CcSEcCtD
Melatonin—Hyperbilirubinaemia—Docetaxel—skin cancer	0.000751	0.00368	CcSEcCtD
Melatonin—Malnutrition—Imiquimod—skin cancer	0.00075	0.00367	CcSEcCtD
Melatonin—Erythema—Imiquimod—skin cancer	0.00075	0.00367	CcSEcCtD
Melatonin—Arthralgia—Vemurafenib—skin cancer	0.000748	0.00366	CcSEcCtD
Melatonin—CALM2—skin of body—skin cancer	0.000746	0.0049	CbGeAlD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000743	0.00364	CcSEcCtD
Melatonin—CALM1—skin of body—skin cancer	0.000742	0.00487	CbGeAlD
Melatonin—Lacrimation increased—Docetaxel—skin cancer	0.000742	0.00363	CcSEcCtD
Melatonin—Vomiting—Vismodegib—skin cancer	0.000738	0.00361	CcSEcCtD
Melatonin—Affect lability—Temozolomide—skin cancer	0.000734	0.00359	CcSEcCtD
Melatonin—Rash—Vismodegib—skin cancer	0.000732	0.00358	CcSEcCtD
Melatonin—Dermatitis—Vismodegib—skin cancer	0.000731	0.00358	CcSEcCtD
Melatonin—Back pain—Imiquimod—skin cancer	0.000725	0.00355	CcSEcCtD
Melatonin—Infection—Vemurafenib—skin cancer	0.000713	0.00349	CcSEcCtD
Melatonin—Mood swings—Temozolomide—skin cancer	0.000707	0.00346	CcSEcCtD
Melatonin—Nervous system disorder—Vemurafenib—skin cancer	0.000703	0.00344	CcSEcCtD
Melatonin—Lethargy—Fluorouracil—skin cancer	0.000701	0.00343	CcSEcCtD
Melatonin—Skin disorder—Vemurafenib—skin cancer	0.000697	0.00341	CcSEcCtD
Melatonin—Nausea—Vismodegib—skin cancer	0.00069	0.00338	CcSEcCtD
Melatonin—MPO—head—skin cancer	0.000689	0.00453	CbGeAlD
Melatonin—Agitation—Imiquimod—skin cancer	0.000689	0.00337	CcSEcCtD
Melatonin—Angioedema—Imiquimod—skin cancer	0.000685	0.00335	CcSEcCtD
Melatonin—Dry skin—Temozolomide—skin cancer	0.000684	0.00335	CcSEcCtD
Melatonin—CALM2—mammalian vulva—skin cancer	0.00068	0.00447	CbGeAlD
Melatonin—CALM1—mammalian vulva—skin cancer	0.000677	0.00445	CbGeAlD
Melatonin—CYP19A1—female reproductive system—skin cancer	0.000674	0.00443	CbGeAlD
Melatonin—Breast disorder—Temozolomide—skin cancer	0.000674	0.0033	CcSEcCtD
Melatonin—Syncope—Imiquimod—skin cancer	0.000672	0.00329	CcSEcCtD
Melatonin—Stomatitis—Bleomycin—skin cancer	0.000664	0.00325	CcSEcCtD
Melatonin—Palpitations—Imiquimod—skin cancer	0.000662	0.00324	CcSEcCtD
Melatonin—Loss of consciousness—Imiquimod—skin cancer	0.000659	0.00322	CcSEcCtD
Melatonin—Irritability—Fluorouracil—skin cancer	0.000656	0.00321	CcSEcCtD
Melatonin—CYP1B1—lymphoid tissue—skin cancer	0.000654	0.00429	CbGeAlD
Melatonin—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000654	0.0032	CcSEcCtD
Melatonin—Haematuria—Bleomycin—skin cancer	0.00065	0.00318	CcSEcCtD
Melatonin—Hypertension—Imiquimod—skin cancer	0.000647	0.00317	CcSEcCtD
Melatonin—Arthralgia—Imiquimod—skin cancer	0.000638	0.00312	CcSEcCtD
Melatonin—Chest pain—Imiquimod—skin cancer	0.000638	0.00312	CcSEcCtD
Melatonin—Anxiety—Imiquimod—skin cancer	0.000636	0.00311	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000634	0.0031	CcSEcCtD
Melatonin—CYP1B1—female reproductive system—skin cancer	0.00063	0.00414	CbGeAlD
Melatonin—Dry skin—Fluorouracil—skin cancer	0.00063	0.00308	CcSEcCtD
Melatonin—NQO2—lymph node—skin cancer	0.000627	0.00412	CbGeAlD
Melatonin—Dry mouth—Imiquimod—skin cancer	0.000624	0.00306	CcSEcCtD
Melatonin—Stomatitis—Dactinomycin—skin cancer	0.000619	0.00303	CcSEcCtD
Melatonin—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000619	0.00303	CcSEcCtD
Melatonin—Fatigue—Vemurafenib—skin cancer	0.000618	0.00303	CcSEcCtD
Melatonin—Nasopharyngitis—Fluorouracil—skin cancer	0.000615	0.00301	CcSEcCtD
Melatonin—Infection—Imiquimod—skin cancer	0.000608	0.00298	CcSEcCtD
Melatonin—ESR1—lymphoid tissue—skin cancer	0.000608	0.00399	CbGeAlD
Melatonin—CALM2—lymphoid tissue—skin cancer	0.000604	0.00397	CbGeAlD
Melatonin—Shock—Imiquimod—skin cancer	0.000602	0.00295	CcSEcCtD
Melatonin—CALM1—lymphoid tissue—skin cancer	0.000601	0.00395	CbGeAlD
Melatonin—Nervous system disorder—Imiquimod—skin cancer	0.0006	0.00294	CcSEcCtD
Melatonin—CYP1A1—epithelium—skin cancer	0.0006	0.00394	CbGeAlD
Melatonin—Skin disorder—Imiquimod—skin cancer	0.000594	0.00291	CcSEcCtD
Melatonin—Weight increased—Temozolomide—skin cancer	0.000587	0.00287	CcSEcCtD
Melatonin—ESR1—female reproductive system—skin cancer	0.000586	0.00385	CbGeAlD
Melatonin—CALM2—female reproductive system—skin cancer	0.000583	0.00382	CbGeAlD
Melatonin—CALM1—female reproductive system—skin cancer	0.00058	0.00381	CbGeAlD
Melatonin—Angina pectoris—Fluorouracil—skin cancer	0.000579	0.00283	CcSEcCtD
Melatonin—Infestation NOS—Temozolomide—skin cancer	0.000575	0.00281	CcSEcCtD
Melatonin—Infestation—Temozolomide—skin cancer	0.000575	0.00281	CcSEcCtD
Melatonin—CYP1A1—skin of body—skin cancer	0.000571	0.00375	CbGeAlD
Melatonin—CYP19A1—head—skin cancer	0.000563	0.0037	CbGeAlD
Melatonin—Stomatitis—Temozolomide—skin cancer	0.00056	0.00274	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000557	0.00273	CcSEcCtD
Melatonin—Insomnia—Imiquimod—skin cancer	0.000553	0.00271	CcSEcCtD
Melatonin—SLC22A8—head—skin cancer	0.000551	0.00362	CbGeAlD
Melatonin—Paraesthesia—Imiquimod—skin cancer	0.000549	0.00269	CcSEcCtD
Melatonin—Somnolence—Imiquimod—skin cancer	0.000544	0.00266	CcSEcCtD
Melatonin—Hepatobiliary disease—Temozolomide—skin cancer	0.000544	0.00266	CcSEcCtD
Melatonin—Dyspepsia—Imiquimod—skin cancer	0.000539	0.00264	CcSEcCtD
Melatonin—Erythema—Bleomycin—skin cancer	0.000533	0.00261	CcSEcCtD
Melatonin—Hot flush—Docetaxel—skin cancer	0.00053	0.0026	CcSEcCtD
Melatonin—Infestation NOS—Fluorouracil—skin cancer	0.00053	0.00259	CcSEcCtD
Melatonin—Infestation—Fluorouracil—skin cancer	0.00053	0.00259	CcSEcCtD
Melatonin—Hypersensitivity—Vemurafenib—skin cancer	0.000529	0.00259	CcSEcCtD
Melatonin—Gastrointestinal disorder—Imiquimod—skin cancer	0.000528	0.00259	CcSEcCtD
Melatonin—Fatigue—Imiquimod—skin cancer	0.000527	0.00258	CcSEcCtD
Melatonin—CYP1B1—head—skin cancer	0.000527	0.00346	CbGeAlD
Melatonin—Menopausal symptoms—Docetaxel—skin cancer	0.000526	0.00257	CcSEcCtD
Melatonin—Pain—Imiquimod—skin cancer	0.000523	0.00256	CcSEcCtD
Melatonin—CYP1A1—mammalian vulva—skin cancer	0.00052	0.00342	CbGeAlD
Melatonin—Stomatitis—Fluorouracil—skin cancer	0.000516	0.00253	CcSEcCtD
Melatonin—Asthenia—Vemurafenib—skin cancer	0.000515	0.00252	CcSEcCtD
Melatonin—Urinary tract disorder—Temozolomide—skin cancer	0.00051	0.00249	CcSEcCtD
Melatonin—Pruritus—Vemurafenib—skin cancer	0.000508	0.00248	CcSEcCtD
Melatonin—Connective tissue disorder—Temozolomide—skin cancer	0.000507	0.00248	CcSEcCtD
Melatonin—Lethargy—Docetaxel—skin cancer	0.000506	0.00248	CcSEcCtD
Melatonin—Urethral disorder—Temozolomide—skin cancer	0.000506	0.00248	CcSEcCtD
Melatonin—Gastrointestinal pain—Imiquimod—skin cancer	0.0005	0.00245	CcSEcCtD
Melatonin—Hyponatraemia—Docetaxel—skin cancer	0.000498	0.00244	CcSEcCtD
Melatonin—Erythema—Dactinomycin—skin cancer	0.000497	0.00243	CcSEcCtD
Melatonin—Pain in extremity—Docetaxel—skin cancer	0.000496	0.00243	CcSEcCtD
Melatonin—ESR1—head—skin cancer	0.00049	0.00321	CbGeAlD
Melatonin—Migraine—Docetaxel—skin cancer	0.000488	0.00239	CcSEcCtD
Melatonin—CALM2—head—skin cancer	0.000487	0.0032	CbGeAlD
Melatonin—CALM1—head—skin cancer	0.000484	0.00318	CbGeAlD
Melatonin—Abdominal pain—Imiquimod—skin cancer	0.000484	0.00237	CcSEcCtD
Melatonin—MPO—lymph node—skin cancer	0.000483	0.00317	CbGeAlD
Melatonin—Eye disorder—Temozolomide—skin cancer	0.000482	0.00236	CcSEcCtD
Melatonin—Cardiac disorder—Temozolomide—skin cancer	0.000479	0.00234	CcSEcCtD
Melatonin—Leukopenia—Bleomycin—skin cancer	0.000477	0.00233	CcSEcCtD
Melatonin—Dizziness—Vemurafenib—skin cancer	0.000474	0.00232	CcSEcCtD
Melatonin—Angiopathy—Temozolomide—skin cancer	0.000468	0.00229	CcSEcCtD
Melatonin—Immune system disorder—Temozolomide—skin cancer	0.000466	0.00228	CcSEcCtD
Melatonin—Liver function test abnormal—Docetaxel—skin cancer	0.000458	0.00224	CcSEcCtD
Melatonin—Vomiting—Vemurafenib—skin cancer	0.000456	0.00223	CcSEcCtD
Melatonin—Dry skin—Docetaxel—skin cancer	0.000455	0.00223	CcSEcCtD
Melatonin—Chest pain—Bleomycin—skin cancer	0.000453	0.00222	CcSEcCtD
Melatonin—Abdominal pain upper—Docetaxel—skin cancer	0.000453	0.00222	CcSEcCtD
Melatonin—Rash—Vemurafenib—skin cancer	0.000452	0.00221	CcSEcCtD
Melatonin—Mental disorder—Temozolomide—skin cancer	0.000452	0.00221	CcSEcCtD
Melatonin—Dermatitis—Vemurafenib—skin cancer	0.000452	0.00221	CcSEcCtD
Melatonin—Hypersensitivity—Imiquimod—skin cancer	0.000451	0.00221	CcSEcCtD
Melatonin—Headache—Vemurafenib—skin cancer	0.000449	0.0022	CcSEcCtD
Melatonin—Erythema—Temozolomide—skin cancer	0.000449	0.0022	CcSEcCtD
Melatonin—Malnutrition—Temozolomide—skin cancer	0.000449	0.0022	CcSEcCtD
Melatonin—Breast disorder—Docetaxel—skin cancer	0.000448	0.00219	CcSEcCtD
Melatonin—CYP1A1—female reproductive system—skin cancer	0.000446	0.00293	CbGeAlD
Melatonin—Leukopenia—Dactinomycin—skin cancer	0.000445	0.00218	CcSEcCtD
Melatonin—Nasopharyngitis—Docetaxel—skin cancer	0.000444	0.00217	CcSEcCtD
Melatonin—Asthenia—Imiquimod—skin cancer	0.000439	0.00215	CcSEcCtD
Melatonin—Back pain—Temozolomide—skin cancer	0.000435	0.00213	CcSEcCtD
Melatonin—CALM3—lymph node—skin cancer	0.000434	0.00285	CbGeAlD
Melatonin—Pruritus—Imiquimod—skin cancer	0.000433	0.00212	CcSEcCtD
Melatonin—Infection—Bleomycin—skin cancer	0.000432	0.00211	CcSEcCtD
Melatonin—CYP2C9—female reproductive system—skin cancer	0.000429	0.00282	CbGeAlD
Melatonin—Nausea—Vemurafenib—skin cancer	0.000426	0.00209	CcSEcCtD
Melatonin—Thrombocytopenia—Bleomycin—skin cancer	0.000426	0.00208	CcSEcCtD
Melatonin—Vision blurred—Temozolomide—skin cancer	0.000423	0.00207	CcSEcCtD
Melatonin—Angina pectoris—Docetaxel—skin cancer	0.000418	0.00204	CcSEcCtD
Melatonin—Erythema—Fluorouracil—skin cancer	0.000414	0.00203	CcSEcCtD
Melatonin—Agitation—Temozolomide—skin cancer	0.000413	0.00202	CcSEcCtD
Melatonin—Angioedema—Temozolomide—skin cancer	0.00041	0.00201	CcSEcCtD
Melatonin—Dizziness—Imiquimod—skin cancer	0.000405	0.00198	CcSEcCtD
Melatonin—Vertigo—Temozolomide—skin cancer	0.000404	0.00198	CcSEcCtD
Melatonin—Infection—Dactinomycin—skin cancer	0.000403	0.00197	CcSEcCtD
Melatonin—Leukopenia—Temozolomide—skin cancer	0.000402	0.00197	CcSEcCtD
Melatonin—Palpitations—Temozolomide—skin cancer	0.000397	0.00194	CcSEcCtD
Melatonin—Thrombocytopenia—Dactinomycin—skin cancer	0.000397	0.00194	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000396	0.00194	CcSEcCtD
Melatonin—CYP19A1—lymph node—skin cancer	0.000394	0.00259	CbGeAlD
Melatonin—Paraesthesia—Bleomycin—skin cancer	0.00039	0.00191	CcSEcCtD
Melatonin—Weight increased—Docetaxel—skin cancer	0.00039	0.00191	CcSEcCtD
Melatonin—Vision blurred—Fluorouracil—skin cancer	0.00039	0.00191	CcSEcCtD
Melatonin—Vomiting—Imiquimod—skin cancer	0.000389	0.0019	CcSEcCtD
Melatonin—Hypertension—Temozolomide—skin cancer	0.000388	0.0019	CcSEcCtD
Melatonin—Rash—Imiquimod—skin cancer	0.000386	0.00189	CcSEcCtD
Melatonin—Dermatitis—Imiquimod—skin cancer	0.000385	0.00189	CcSEcCtD
Melatonin—Headache—Imiquimod—skin cancer	0.000383	0.00188	CcSEcCtD
Melatonin—Arthralgia—Temozolomide—skin cancer	0.000382	0.00187	CcSEcCtD
Melatonin—Infestation—Docetaxel—skin cancer	0.000382	0.00187	CcSEcCtD
Melatonin—Infestation NOS—Docetaxel—skin cancer	0.000382	0.00187	CcSEcCtD
Melatonin—Anxiety—Temozolomide—skin cancer	0.000381	0.00187	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00038	0.00186	CcSEcCtD
Melatonin—Dry mouth—Temozolomide—skin cancer	0.000374	0.00183	CcSEcCtD
Melatonin—Stomatitis—Docetaxel—skin cancer	0.000373	0.00182	CcSEcCtD
Melatonin—CYP1A1—head—skin cancer	0.000372	0.00244	CbGeAlD
Melatonin—Pain—Bleomycin—skin cancer	0.000372	0.00182	CcSEcCtD
Melatonin—Leukopenia—Fluorouracil—skin cancer	0.00037	0.00181	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000369	0.00181	CcSEcCtD
Melatonin—CYP1B1—lymph node—skin cancer	0.000369	0.00242	CbGeAlD
Melatonin—Infection—Temozolomide—skin cancer	0.000364	0.00178	CcSEcCtD
Melatonin—Nausea—Imiquimod—skin cancer	0.000363	0.00178	CcSEcCtD
Melatonin—Hepatobiliary disease—Docetaxel—skin cancer	0.000362	0.00177	CcSEcCtD
Melatonin—Nervous system disorder—Temozolomide—skin cancer	0.00036	0.00176	CcSEcCtD
Melatonin—Thrombocytopenia—Temozolomide—skin cancer	0.000359	0.00176	CcSEcCtD
Melatonin—Skin disorder—Temozolomide—skin cancer	0.000356	0.00174	CcSEcCtD
Melatonin—Chest pain—Fluorouracil—skin cancer	0.000352	0.00172	CcSEcCtD
Melatonin—Fatigue—Dactinomycin—skin cancer	0.000349	0.00171	CcSEcCtD
Melatonin—Pain—Dactinomycin—skin cancer	0.000347	0.0017	CcSEcCtD
Melatonin—ESR1—lymph node—skin cancer	0.000343	0.00225	CbGeAlD
Melatonin—CALM2—lymph node—skin cancer	0.000341	0.00224	CbGeAlD
Melatonin—CALM1—lymph node—skin cancer	0.000339	0.00223	CbGeAlD
Melatonin—Urinary tract disorder—Docetaxel—skin cancer	0.000339	0.00166	CcSEcCtD
Melatonin—Connective tissue disorder—Docetaxel—skin cancer	0.000337	0.00165	CcSEcCtD
Melatonin—Urethral disorder—Docetaxel—skin cancer	0.000336	0.00165	CcSEcCtD
Melatonin—Infection—Fluorouracil—skin cancer	0.000336	0.00164	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000334	0.00164	CcSEcCtD
Melatonin—Insomnia—Temozolomide—skin cancer	0.000332	0.00162	CcSEcCtD
Melatonin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000331	0.00162	CcSEcCtD
Melatonin—Nervous system disorder—Fluorouracil—skin cancer	0.000331	0.00162	CcSEcCtD
Melatonin—Thrombocytopenia—Fluorouracil—skin cancer	0.000331	0.00162	CcSEcCtD
Melatonin—Paraesthesia—Temozolomide—skin cancer	0.000329	0.00161	CcSEcCtD
Melatonin—Somnolence—Temozolomide—skin cancer	0.000326	0.0016	CcSEcCtD
Melatonin—Dyspepsia—Temozolomide—skin cancer	0.000323	0.00158	CcSEcCtD
Melatonin—Eye disorder—Docetaxel—skin cancer	0.000321	0.00157	CcSEcCtD
Melatonin—Abdominal pain—Dactinomycin—skin cancer	0.00032	0.00157	CcSEcCtD
Melatonin—Hypersensitivity—Bleomycin—skin cancer	0.00032	0.00157	CcSEcCtD
Melatonin—Cardiac disorder—Docetaxel—skin cancer	0.000318	0.00156	CcSEcCtD
Melatonin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000317	0.00155	CcSEcCtD
Melatonin—Fatigue—Temozolomide—skin cancer	0.000316	0.00155	CcSEcCtD
Melatonin—Pain—Temozolomide—skin cancer	0.000314	0.00153	CcSEcCtD
Melatonin—Asthenia—Bleomycin—skin cancer	0.000312	0.00153	CcSEcCtD
Melatonin—Angiopathy—Docetaxel—skin cancer	0.000311	0.00152	CcSEcCtD
Melatonin—Immune system disorder—Docetaxel—skin cancer	0.00031	0.00152	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000308	0.00151	CcSEcCtD
Melatonin—Pruritus—Bleomycin—skin cancer	0.000307	0.00151	CcSEcCtD
Melatonin—Insomnia—Fluorouracil—skin cancer	0.000306	0.0015	CcSEcCtD
Melatonin—Paraesthesia—Fluorouracil—skin cancer	0.000303	0.00148	CcSEcCtD
Melatonin—Mental disorder—Docetaxel—skin cancer	0.000301	0.00147	CcSEcCtD
Melatonin—Somnolence—Fluorouracil—skin cancer	0.0003	0.00147	CcSEcCtD
Melatonin—Gastrointestinal pain—Temozolomide—skin cancer	0.0003	0.00147	CcSEcCtD
Melatonin—Erythema—Docetaxel—skin cancer	0.000299	0.00146	CcSEcCtD
Melatonin—Malnutrition—Docetaxel—skin cancer	0.000299	0.00146	CcSEcCtD
Melatonin—Hypersensitivity—Dactinomycin—skin cancer	0.000299	0.00146	CcSEcCtD
Melatonin—Dyspepsia—Fluorouracil—skin cancer	0.000297	0.00146	CcSEcCtD
Melatonin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000292	0.00143	CcSEcCtD
Melatonin—Asthenia—Dactinomycin—skin cancer	0.000291	0.00142	CcSEcCtD
Melatonin—Abdominal pain—Temozolomide—skin cancer	0.00029	0.00142	CcSEcCtD
Melatonin—Back pain—Docetaxel—skin cancer	0.000289	0.00141	CcSEcCtD
Melatonin—Pain—Fluorouracil—skin cancer	0.000289	0.00141	CcSEcCtD
Melatonin—Muscle spasms—Docetaxel—skin cancer	0.000287	0.00141	CcSEcCtD
Melatonin—Vomiting—Bleomycin—skin cancer	0.000276	0.00135	CcSEcCtD
Melatonin—Rash—Bleomycin—skin cancer	0.000274	0.00134	CcSEcCtD
Melatonin—Dermatitis—Bleomycin—skin cancer	0.000274	0.00134	CcSEcCtD
Melatonin—Hypersensitivity—Temozolomide—skin cancer	0.00027	0.00132	CcSEcCtD
Melatonin—Syncope—Docetaxel—skin cancer	0.000268	0.00131	CcSEcCtD
Melatonin—Leukopenia—Docetaxel—skin cancer	0.000267	0.00131	CcSEcCtD
Melatonin—Palpitations—Docetaxel—skin cancer	0.000264	0.00129	CcSEcCtD
Melatonin—Asthenia—Temozolomide—skin cancer	0.000263	0.00129	CcSEcCtD
Melatonin—Loss of consciousness—Docetaxel—skin cancer	0.000263	0.00129	CcSEcCtD
Melatonin—CYP1A1—lymph node—skin cancer	0.000261	0.00171	CbGeAlD
Melatonin—Pruritus—Temozolomide—skin cancer	0.000259	0.00127	CcSEcCtD
Melatonin—Nausea—Bleomycin—skin cancer	0.000258	0.00126	CcSEcCtD
Melatonin—Hypertension—Docetaxel—skin cancer	0.000258	0.00126	CcSEcCtD
Melatonin—Vomiting—Dactinomycin—skin cancer	0.000258	0.00126	CcSEcCtD
Melatonin—Rash—Dactinomycin—skin cancer	0.000256	0.00125	CcSEcCtD
Melatonin—Arthralgia—Docetaxel—skin cancer	0.000254	0.00124	CcSEcCtD
Melatonin—Chest pain—Docetaxel—skin cancer	0.000254	0.00124	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000253	0.00124	CcSEcCtD
Melatonin—Hypersensitivity—Fluorouracil—skin cancer	0.000249	0.00122	CcSEcCtD
Melatonin—Dry mouth—Docetaxel—skin cancer	0.000249	0.00122	CcSEcCtD
Melatonin—Dizziness—Temozolomide—skin cancer	0.000242	0.00119	CcSEcCtD
Melatonin—Infection—Docetaxel—skin cancer	0.000242	0.00119	CcSEcCtD
Melatonin—Nausea—Dactinomycin—skin cancer	0.000241	0.00118	CcSEcCtD
Melatonin—Shock—Docetaxel—skin cancer	0.00024	0.00117	CcSEcCtD
Melatonin—Nervous system disorder—Docetaxel—skin cancer	0.000239	0.00117	CcSEcCtD
Melatonin—Pruritus—Fluorouracil—skin cancer	0.000239	0.00117	CcSEcCtD
Melatonin—Thrombocytopenia—Docetaxel—skin cancer	0.000239	0.00117	CcSEcCtD
Melatonin—Skin disorder—Docetaxel—skin cancer	0.000237	0.00116	CcSEcCtD
Melatonin—Vomiting—Temozolomide—skin cancer	0.000233	0.00114	CcSEcCtD
Melatonin—Rash—Temozolomide—skin cancer	0.000231	0.00113	CcSEcCtD
Melatonin—Dermatitis—Temozolomide—skin cancer	0.000231	0.00113	CcSEcCtD
Melatonin—Headache—Temozolomide—skin cancer	0.00023	0.00112	CcSEcCtD
Melatonin—Dizziness—Fluorouracil—skin cancer	0.000223	0.00109	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000222	0.00109	CcSEcCtD
Melatonin—Insomnia—Docetaxel—skin cancer	0.000221	0.00108	CcSEcCtD
Melatonin—Paraesthesia—Docetaxel—skin cancer	0.000219	0.00107	CcSEcCtD
Melatonin—Nausea—Temozolomide—skin cancer	0.000218	0.00107	CcSEcCtD
Melatonin—Somnolence—Docetaxel—skin cancer	0.000217	0.00106	CcSEcCtD
Melatonin—Vomiting—Fluorouracil—skin cancer	0.000215	0.00105	CcSEcCtD
Melatonin—Dyspepsia—Docetaxel—skin cancer	0.000215	0.00105	CcSEcCtD
Melatonin—Rash—Fluorouracil—skin cancer	0.000213	0.00104	CcSEcCtD
Melatonin—Dermatitis—Fluorouracil—skin cancer	0.000213	0.00104	CcSEcCtD
Melatonin—Headache—Fluorouracil—skin cancer	0.000212	0.00104	CcSEcCtD
Melatonin—Gastrointestinal disorder—Docetaxel—skin cancer	0.00021	0.00103	CcSEcCtD
Melatonin—Fatigue—Docetaxel—skin cancer	0.00021	0.00103	CcSEcCtD
Melatonin—Pain—Docetaxel—skin cancer	0.000208	0.00102	CcSEcCtD
Melatonin—Nausea—Fluorouracil—skin cancer	0.000201	0.000982	CcSEcCtD
Melatonin—Gastrointestinal pain—Docetaxel—skin cancer	0.000199	0.000976	CcSEcCtD
Melatonin—Abdominal pain—Docetaxel—skin cancer	0.000193	0.000943	CcSEcCtD
Melatonin—Hypersensitivity—Docetaxel—skin cancer	0.00018	0.000879	CcSEcCtD
Melatonin—Asthenia—Docetaxel—skin cancer	0.000175	0.000856	CcSEcCtD
Melatonin—Pruritus—Docetaxel—skin cancer	0.000172	0.000844	CcSEcCtD
Melatonin—Dizziness—Docetaxel—skin cancer	0.000161	0.000789	CcSEcCtD
Melatonin—Vomiting—Docetaxel—skin cancer	0.000155	0.000759	CcSEcCtD
Melatonin—Rash—Docetaxel—skin cancer	0.000154	0.000752	CcSEcCtD
Melatonin—Dermatitis—Docetaxel—skin cancer	0.000154	0.000752	CcSEcCtD
Melatonin—Headache—Docetaxel—skin cancer	0.000153	0.000748	CcSEcCtD
Melatonin—Nausea—Docetaxel—skin cancer	0.000145	0.000709	CcSEcCtD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	2.86e-05	0.000273	CbGpPWpGaD
Melatonin—CALM2—Downstream signal transduction—IL6—skin cancer	2.85e-05	0.000273	CbGpPWpGaD
Melatonin—CALM1—Downstream signal transduction—IL6—skin cancer	2.85e-05	0.000273	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR—IL6—skin cancer	2.84e-05	0.000271	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR—IL6—skin cancer	2.84e-05	0.000271	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—HRAS—skin cancer	2.83e-05	0.000271	CbGpPWpGaD
Melatonin—CALM2—Signaling by ERBB2—IL6—skin cancer	2.83e-05	0.00027	CbGpPWpGaD
Melatonin—CALM1—Signaling by ERBB2—IL6—skin cancer	2.83e-05	0.00027	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GLI1—skin cancer	2.82e-05	0.00027	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GLI1—skin cancer	2.82e-05	0.00027	CbGpPWpGaD
Melatonin—CALM2—DAP12 signaling—IL6—skin cancer	2.81e-05	0.000269	CbGpPWpGaD
Melatonin—CALM1—DAP12 signaling—IL6—skin cancer	2.81e-05	0.000269	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—HRAS—skin cancer	2.81e-05	0.000268	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—HRAS—skin cancer	2.79e-05	0.000267	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PTGER4—skin cancer	2.79e-05	0.000266	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PLIN2—skin cancer	2.78e-05	0.000266	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SUFU—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—HRAS—skin cancer	2.76e-05	0.000264	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—HRAS—skin cancer	2.74e-05	0.000262	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—HRAS—skin cancer	2.74e-05	0.000262	CbGpPWpGaD
Melatonin—CALM3—DAP12 interactions—IL6—skin cancer	2.73e-05	0.000261	CbGpPWpGaD
Melatonin—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.73e-05	0.000261	CbGpPWpGaD
Melatonin—CALM3—Signaling by FGFR in disease—IL6—skin cancer	2.73e-05	0.000261	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—HRAS—skin cancer	2.71e-05	0.00026	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—HRAS—skin cancer	2.71e-05	0.00026	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR—IL6—skin cancer	2.71e-05	0.000259	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—HRAS—skin cancer	2.7e-05	0.000258	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—HRAS—skin cancer	2.7e-05	0.000258	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—ERCC2—skin cancer	2.7e-05	0.000258	CbGpPWpGaD
Melatonin—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	2.69e-05	0.000257	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SUFU—skin cancer	2.67e-05	0.000256	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SUFU—skin cancer	2.67e-05	0.000256	CbGpPWpGaD
Melatonin—CALM3—Signaling by PDGF—IL6—skin cancer	2.67e-05	0.000256	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—NRAS—skin cancer	2.66e-05	0.000254	CbGpPWpGaD
Melatonin—CALM3—Immune System—FOXO4—skin cancer	2.66e-05	0.000254	CbGpPWpGaD
Melatonin—CALM1—Signaling by FGFR in disease—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM2—DAP12 interactions—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM1—DAP12 interactions—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM2—Signaling by FGFR in disease—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.65e-05	0.000253	CbGpPWpGaD
Melatonin—CALM3—B Cell Activation—HRAS—skin cancer	2.64e-05	0.000253	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CSPG4—skin cancer	2.63e-05	0.000251	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR—IL6—skin cancer	2.62e-05	0.000251	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR—IL6—skin cancer	2.62e-05	0.000251	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—KRAS—skin cancer	2.62e-05	0.00025	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—KRAS—skin cancer	2.62e-05	0.00025	CbGpPWpGaD
Melatonin—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	2.6e-05	0.000248	CbGpPWpGaD
Melatonin—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	2.6e-05	0.000248	CbGpPWpGaD
Melatonin—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	2.59e-05	0.000248	CbGpPWpGaD
Melatonin—CALM2—Signaling by PDGF—IL6—skin cancer	2.59e-05	0.000247	CbGpPWpGaD
Melatonin—CALM1—Signaling by PDGF—IL6—skin cancer	2.59e-05	0.000247	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—NRAS—skin cancer	2.57e-05	0.000246	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—NRAS—skin cancer	2.57e-05	0.000246	CbGpPWpGaD
Melatonin—CALM2—Immune System—FOXO4—skin cancer	2.57e-05	0.000246	CbGpPWpGaD
Melatonin—CALM1—Immune System—FOXO4—skin cancer	2.57e-05	0.000246	CbGpPWpGaD
Melatonin—CALM1—B Cell Activation—HRAS—skin cancer	2.56e-05	0.000245	CbGpPWpGaD
Melatonin—CALM2—B Cell Activation—HRAS—skin cancer	2.56e-05	0.000245	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.53e-05	0.000242	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ENO2—skin cancer	2.52e-05	0.000241	CbGpPWpGaD
Melatonin—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	2.51e-05	0.00024	CbGpPWpGaD
Melatonin—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	2.51e-05	0.00024	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—FOXO4—skin cancer	2.46e-05	0.000235	CbGpPWpGaD
Melatonin—CALM3—Disease—FOXO4—skin cancer	2.45e-05	0.000235	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.45e-05	0.000234	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.45e-05	0.000234	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ENO2—skin cancer	2.44e-05	0.000233	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ENO2—skin cancer	2.44e-05	0.000233	CbGpPWpGaD
Melatonin—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.42e-05	0.000232	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ENO2—skin cancer	2.39e-05	0.000229	CbGpPWpGaD
Melatonin—CALM2—Disease—FOXO4—skin cancer	2.37e-05	0.000227	CbGpPWpGaD
Melatonin—CALM1—Disease—FOXO4—skin cancer	2.37e-05	0.000227	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—ERCC2—skin cancer	2.34e-05	0.000224	CbGpPWpGaD
Melatonin—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.34e-05	0.000224	CbGpPWpGaD
Melatonin—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.34e-05	0.000224	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—skin cancer	2.33e-05	0.000223	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—skin cancer	2.33e-05	0.000223	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—KRAS—skin cancer	2.29e-05	0.000219	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—ERCC2—skin cancer	2.26e-05	0.000216	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CSPG4—skin cancer	2.24e-05	0.000215	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—HRAS—skin cancer	2.23e-05	0.000213	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—HRAS—skin cancer	2.23e-05	0.000213	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—KRAS—skin cancer	2.22e-05	0.000212	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—KRAS—skin cancer	2.22e-05	0.000212	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—IL6—skin cancer	2.13e-05	0.000204	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—IL6—skin cancer	2.13e-05	0.000204	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SHH—skin cancer	2.11e-05	0.000202	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RASA1—skin cancer	2.1e-05	0.0002	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SHH—skin cancer	2.04e-05	0.000195	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SHH—skin cancer	2.04e-05	0.000195	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RASA1—skin cancer	2.03e-05	0.000194	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RASA1—skin cancer	2.03e-05	0.000194	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTCH1—skin cancer	2e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SMO—skin cancer	2e-05	0.000191	CbGpPWpGaD
Melatonin—CALM3—Neuronal System—HRAS—skin cancer	1.99e-05	0.00019	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ENO2—skin cancer	1.96e-05	0.000187	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—HRAS—skin cancer	1.95e-05	0.000186	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PTGER4—skin cancer	1.95e-05	0.000186	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SMO—skin cancer	1.93e-05	0.000185	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SMO—skin cancer	1.93e-05	0.000185	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTCH1—skin cancer	1.93e-05	0.000185	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTCH1—skin cancer	1.93e-05	0.000185	CbGpPWpGaD
Melatonin—CALM2—Neuronal System—HRAS—skin cancer	1.92e-05	0.000184	CbGpPWpGaD
Melatonin—CALM1—Neuronal System—HRAS—skin cancer	1.92e-05	0.000184	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—HRAS—skin cancer	1.88e-05	0.00018	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—HRAS—skin cancer	1.88e-05	0.00018	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PTGER4—skin cancer	1.88e-05	0.00018	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PTGER4—skin cancer	1.88e-05	0.00018	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.87e-05	0.000179	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—IL6—skin cancer	1.86e-05	0.000178	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—IL6—skin cancer	1.8e-05	0.000172	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—IL6—skin cancer	1.8e-05	0.000172	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ENO2—skin cancer	1.79e-05	0.000171	CbGpPWpGaD
Melatonin—CALM3—Disease—ERCC2—skin cancer	1.75e-05	0.000167	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—FOXO4—skin cancer	1.72e-05	0.000164	CbGpPWpGaD
Melatonin—CALM1—Disease—ERCC2—skin cancer	1.69e-05	0.000162	CbGpPWpGaD
Melatonin—CALM2—Disease—ERCC2—skin cancer	1.69e-05	0.000162	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—NRAS—skin cancer	1.69e-05	0.000161	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—FOXO4—skin cancer	1.66e-05	0.000159	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—FOXO4—skin cancer	1.66e-05	0.000159	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TERT—skin cancer	1.64e-05	0.000157	CbGpPWpGaD
Melatonin—CALM3—Disease—TERT—skin cancer	1.64e-05	0.000157	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—NRAS—skin cancer	1.63e-05	0.000156	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—NRAS—skin cancer	1.63e-05	0.000156	CbGpPWpGaD
Melatonin—CALM1—Disease—TERT—skin cancer	1.59e-05	0.000152	CbGpPWpGaD
Melatonin—CALM2—Disease—TERT—skin cancer	1.59e-05	0.000152	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.53e-05	0.000146	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ENO2—skin cancer	1.53e-05	0.000146	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—NRAS—skin cancer	1.52e-05	0.000145	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—NRAS—skin cancer	1.47e-05	0.00014	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—NRAS—skin cancer	1.47e-05	0.00014	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ERCC2—skin cancer	1.46e-05	0.00014	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—NRAS—skin cancer	1.46e-05	0.000139	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—KRAS—skin cancer	1.45e-05	0.000139	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ERCC2—skin cancer	1.42e-05	0.000135	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ERCC2—skin cancer	1.42e-05	0.000135	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—NRAS—skin cancer	1.41e-05	0.000135	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—NRAS—skin cancer	1.41e-05	0.000135	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—skin cancer	1.41e-05	0.000134	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—KRAS—skin cancer	1.4e-05	0.000134	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—KRAS—skin cancer	1.4e-05	0.000134	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.4e-05	0.000133	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ERCC2—skin cancer	1.39e-05	0.000133	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—skin cancer	1.35e-05	0.000129	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—KRAS—skin cancer	1.31e-05	0.000125	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—BRAF—skin cancer	1.3e-05	0.000125	CbGpPWpGaD
Melatonin—CALM3—Disease—BRAF—skin cancer	1.3e-05	0.000124	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—skin cancer	1.29e-05	0.000123	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—KRAS—skin cancer	1.26e-05	0.000121	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—KRAS—skin cancer	1.26e-05	0.000121	CbGpPWpGaD
Melatonin—CALM1—Disease—BRAF—skin cancer	1.26e-05	0.00012	CbGpPWpGaD
Melatonin—CALM2—Disease—BRAF—skin cancer	1.26e-05	0.00012	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—KRAS—skin cancer	1.25e-05	0.00012	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—skin cancer	1.25e-05	0.000119	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—skin cancer	1.25e-05	0.000119	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—HRAS—skin cancer	1.23e-05	0.000118	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—KRAS—skin cancer	1.21e-05	0.000116	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—KRAS—skin cancer	1.21e-05	0.000116	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.19e-05	0.000114	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—HRAS—skin cancer	1.19e-05	0.000114	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—HRAS—skin cancer	1.19e-05	0.000114	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TERT—skin cancer	1.15e-05	0.00011	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ERCC2—skin cancer	1.14e-05	0.000109	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000106	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TERT—skin cancer	1.11e-05	0.000106	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—HRAS—skin cancer	1.11e-05	0.000106	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—HRAS—skin cancer	1.07e-05	0.000103	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—HRAS—skin cancer	1.07e-05	0.000103	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—HRAS—skin cancer	1.07e-05	0.000102	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—IL6—skin cancer	1.06e-05	0.000102	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—skin cancer	1.05e-05	0.0001	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ERCC2—skin cancer	1.04e-05	9.91e-05	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—HRAS—skin cancer	1.03e-05	9.86e-05	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—HRAS—skin cancer	1.03e-05	9.86e-05	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IL6—skin cancer	1.03e-05	9.83e-05	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IL6—skin cancer	1.03e-05	9.83e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—skin cancer	1.01e-05	9.7e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—skin cancer	1.01e-05	9.7e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—NRAS—skin cancer	9.67e-06	9.25e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—NRAS—skin cancer	9.36e-06	8.95e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—NRAS—skin cancer	9.36e-06	8.95e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—BRAF—skin cancer	9.09e-06	8.69e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ERCC2—skin cancer	8.86e-06	8.47e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—NRAS—skin cancer	8.84e-06	8.45e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—BRAF—skin cancer	8.8e-06	8.41e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—BRAF—skin cancer	8.8e-06	8.41e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—skin cancer	8.78e-06	8.4e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—NRAS—skin cancer	8.55e-06	8.17e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—NRAS—skin cancer	8.55e-06	8.17e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—skin cancer	8.5e-06	8.12e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—skin cancer	8.5e-06	8.12e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—skin cancer	8.33e-06	7.97e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—KRAS—skin cancer	8.33e-06	7.96e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NRAS—skin cancer	8.19e-06	7.83e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NRAS—skin cancer	8.16e-06	7.8e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—KRAS—skin cancer	8.05e-06	7.7e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—KRAS—skin cancer	8.05e-06	7.7e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NRAS—skin cancer	7.89e-06	7.55e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NRAS—skin cancer	7.89e-06	7.55e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—KRAS—skin cancer	7.61e-06	7.27e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—KRAS—skin cancer	7.36e-06	7.03e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—KRAS—skin cancer	7.36e-06	7.03e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—HRAS—skin cancer	7.08e-06	6.77e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—KRAS—skin cancer	7.04e-06	6.73e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—KRAS—skin cancer	7.02e-06	6.71e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—HRAS—skin cancer	6.85e-06	6.54e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—HRAS—skin cancer	6.85e-06	6.54e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—skin cancer	6.82e-06	6.52e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—KRAS—skin cancer	6.79e-06	6.5e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—KRAS—skin cancer	6.79e-06	6.5e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—skin cancer	6.77e-06	6.48e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—skin cancer	6.55e-06	6.26e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—skin cancer	6.55e-06	6.26e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—HRAS—skin cancer	6.47e-06	6.18e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—skin cancer	6.26e-06	5.99e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—HRAS—skin cancer	6.25e-06	5.98e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—HRAS—skin cancer	6.25e-06	5.98e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—skin cancer	6.22e-06	5.95e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—skin cancer	6.19e-06	5.92e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—HRAS—skin cancer	5.99e-06	5.72e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—skin cancer	5.99e-06	5.72e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—skin cancer	5.99e-06	5.72e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—HRAS—skin cancer	5.97e-06	5.71e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—HRAS—skin cancer	5.77e-06	5.52e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—HRAS—skin cancer	5.77e-06	5.52e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—skin cancer	5.73e-06	5.48e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NRAS—skin cancer	5.71e-06	5.46e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—skin cancer	5.71e-06	5.46e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NRAS—skin cancer	5.53e-06	5.28e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NRAS—skin cancer	5.53e-06	5.28e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—skin cancer	5.53e-06	5.28e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—skin cancer	5.53e-06	5.28e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—skin cancer	5.31e-06	5.08e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—KRAS—skin cancer	4.92e-06	4.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—KRAS—skin cancer	4.76e-06	4.55e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—KRAS—skin cancer	4.76e-06	4.55e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—skin cancer	4.37e-06	4.18e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—skin cancer	4.23e-06	4.04e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—skin cancer	4.23e-06	4.04e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HRAS—skin cancer	4.18e-06	4e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HRAS—skin cancer	4.04e-06	3.87e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HRAS—skin cancer	4.04e-06	3.87e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—skin cancer	4e-06	3.83e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—skin cancer	3.87e-06	3.7e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—skin cancer	3.87e-06	3.7e-05	CbGpPWpGaD
